Australia's Optiscan rises after imaging more than 80 cases in ACL study

Australian Clinical Labs

10/09/2026 02:40

** Shares of Australia's Optiscan Imaging OIL.AX rise as much as 10% to A$0.165, their biggest intraday pct gain since August 19
** Shares hit their highest levels since August 27
** The medical technology firm says it has imaged more than 80 cases in a study with Australian Clinical Labs (ACL) using its InForm digital pathology imaging device
** Company says study uses InForm device for real-time, slide-free cellular imaging at point of contact, in real-world pathology environment
** Optiscan stock up 60%, YTD 


 (Reporting by Subhalakshmi Dey in Bengaluru)
 ((Subhalakshmi.Dey@thomsonreuters.com;))